Cognition Therapeutics, Inc. Common Stock
Symbol: CGTX (NASDAQ)
2.50
▼ (-1.19%) -0.030
Company Description:
Cognition Therapeutics Inc is a clinical-stage biopharmaceutical company engaged in the discovery and development of, small-molecule therapeutics targeting age-related degenerative diseases and disorders of the central nervous system and retina. Its product candidate CT1812, is an orally delivered, small-molecule antagonist designed to penetrate the blood-brain barrier and bind selectively to the S2R complex.
Key Stats
- Today's Open: $2.49
- Today's High: $2.585
- Today's Low: $2.435
- Today's Volume: 3.25M
- Yesterday Close: $2.53
- Yesterday High: $2.53
- Yesterday Low: $2.37
- Yesterday Volume: 2.17M
- Last Min Volume: 101
- Last Min High: $2.5
- Last Min Low: $2.483
- Last Min VWAP: $2.49884
Company Profile
- Name: Cognition Therapeutics, Inc. Common Stock
- Website: https://www.cogrx.com
- Listed Date: 2021-10-08
- Location: PITTSBURGH, PA
- Market Status: Active
- CIK Number: 0001455365
- SIC Code: 2836
- SIC description: BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)
- Market Cap: $211.74M
- Round Lot: 100
- Outstanding Shares: 88.22M
- Asset Type: CS
RECENT FILINGS FOR CGTX
| Filing Date | Filing Type | Format |
|---|---|---|
| 2025-08-28 | 8-K | View |
| 2025-08-28 | 424B5 | View |
| 2025-08-26 | 8-K | View |
| 2025-08-07 | 8-K | View |
| 2025-08-07 | 10-Q | View |
| 2025-07-31 | 4 | View |
| 2025-07-31 | 4 | View |
| 2025-07-31 | 4 | View |
| 2025-06-23 | 4 | View |
| 2025-06-23 | 4 | View |
| 2025-06-23 | 4 | View |
| 2025-06-23 | 4 | View |
| 2025-06-20 | 4 | View |
| 2025-06-20 | 4 | View |
| 2025-06-20 | 8-K | View |
| 2025-06-03 | 8-K | View |
| 2025-06-02 | 8-K | View |
| 2025-05-08 | 8-K | View |
| 2025-05-07 | 10-Q | View |
| 2025-05-07 | 8-K | View |
Latest News on CGTX